BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28476018)

  • 1. Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma.
    Vakiani E; Shah RH; Berger MF; Makohon-Moore AP; Reiter JG; Ostrovnaya I; Attiyeh MA; Cercek A; Shia J; Iacobuzio-Donahue CA; Solit DB; Weiser MR
    Oncotarget; 2017 Jun; 8(26):42487-42494. PubMed ID: 28476018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between KRAS G13D mutations and anastomotic recurrence in colorectal cancer: Two case reports.
    Okada S; Hata K; Kawai K; Yamamoto Y; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Emoto S; Murono K; Nozawa H
    Medicine (Baltimore); 2019 Mar; 98(12):e14781. PubMed ID: 30896620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
    Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
    Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
    Italiano A; Hostein I; Soubeyran I; Fabas T; Benchimol D; Evrard S; Gugenheim J; Becouarn Y; Brunet R; Fonck M; François E; Saint-Paul MC; Pedeutour F
    Ann Surg Oncol; 2010 May; 17(5):1429-34. PubMed ID: 20049644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
    Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
    Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
    Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
    PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph Node Metastases in Colon Cancer Are Polyclonal.
    Ulintz PJ; Greenson JK; Wu R; Fearon ER; Hardiman KM
    Clin Cancer Res; 2018 May; 24(9):2214-2224. PubMed ID: 29203589
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
    Takahashi Y; Sugai T; Habano W; Ishida K; Eizuka M; Otsuka K; Sasaki A; Takayuki Matsumoto ; Morikawa T; Unno M; Suzuki H
    Int J Cancer; 2016 Dec; 139(11):2493-501. PubMed ID: 27509333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal origins and parallel evolution of regionally synchronous colorectal adenoma and carcinoma.
    Kim TM; An CH; Rhee JK; Jung SH; Lee SH; Baek IP; Kim MS; Lee SH; Chung YJ
    Oncotarget; 2015 Sep; 6(29):27725-35. PubMed ID: 26336987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
    Li W; Qiu T; Guo L; Ying J
    Cancer Lett; 2017 Dec; 410():92-99. PubMed ID: 28942013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutational Heterogeneity in
    Gausachs M; Borras E; Chang K; Gonzalez S; Azuara D; Delgado Amador A; Lopez-Doriga A; San Lucas FA; Sanjuan X; Paules MJ; Taggart MW; Davies GE; Ehli EA; Fowler J; Moreno V; Pineda M; You YN; Lynch PM; Lazaro C; Navin NE; Scheet PA; Hawk ET; Capella G; Vilar E
    Clin Cancer Res; 2017 Oct; 23(19):5936-5947. PubMed ID: 28645942
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
    Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
    Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors.
    Goswami RS; Patel KP; Singh RR; Meric-Bernstam F; Kopetz ES; Subbiah V; Alvarez RH; Davies MA; Jabbar KJ; Roy-Chowdhuri S; Lazar AJ; Medeiros LJ; Broaddus RR; Luthra R; Routbort MJ
    Clin Cancer Res; 2015 Jun; 21(11):2644-51. PubMed ID: 25695693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.
    Baldus SE; Schaefer KL; Engers R; Hartleb D; Stoecklein NH; Gabbert HE
    Clin Cancer Res; 2010 Feb; 16(3):790-9. PubMed ID: 20103678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers.
    Kleist B; Meurer T; Poetsch M
    Tumour Biol; 2017 Mar; 39(3):1010428317692246. PubMed ID: 28345467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
    Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.